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to an endemic problem in the hospital, which has
resulted in a concurrent dissemination of genes,
plasmids and strains.
Although ESBLs were present in 88.2% of
resistant isolates, 11.8% of isolates had a pheno-
type characteristic of AmpC-type b-lactamases.
Plasmid-mediated AmpC-type b-lactamases have
been reported in isolates of K. pneumoniae, E. coli,
Salmonella spp., Citrobacter freundii, Enterobacter
aerogenes and P. mirabilis [4,5]. The first AmpC-
type b-lactamase to be identified in Tunis was in
1996 in a P. mirabilis isolate, and was characterised
as a CMY-4 enzyme that conferred resistance to
all cephalosporins, including cephamycins, and
was related to the chromosomal enzyme of C.
freundii [8]. Subsequently, such enzymes were
found in a variety of enterobacteria, particularly
E. coli and K. pneumoniae [5,8]. The rapid increase
in the number and variety of enzymes conferring
resistance to third-generation cephalosporins has
now became a serious problem with major thera-
peutic implications, which emphasises the neces-
sity of implementing infection control measures
and promoting the rational use of antibiotics.
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A B S T R A C T
Data on BacT ⁄Alert blood cultures in a Greek
hospital from 1995 to 2002 were analysed retro-
spectively. There was a gradual increase in the
number of blood cultures (4981 in 1995 to 9054 in
2002), the true positive rate (14.4% to 16.5%) and
the number of bloodstream infections ⁄ 1000 hos-
pital admissions (22.1 to 30.7). The five most
common pathogens were Eschericia coli, Staphylo-
coccus aureus, coagulase-negative staphylococci,
enterococci and Klebsiella spp. The relative rates of
Gram-negative and Gram-positive isolates
inverted during the study period because of an
increasing frequency of coagulase-negative sta-
phylococci and enterococci.
Corresponding author and reprint requests: A. Avlami, Micro-
biology Department, ‘Laikon’ General Hospital, 3 Diadochou
Pavlou str, Paleon Psychikon 15452, Greece
E-mail: gab@hol.gr
Research Note 667
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 657–678
Keywords Blood cultures, coagulase-negative sta-
phylococci, enterococci, Escherichia coli, Klebsiella, sta-
phylococci
Original Submission: 28 September 2003; Revised
Submission: 29 November 2003; Accepted: 8 Decem-
ber 2003
Clin Microbiol Infect 2004; 10: 667–670
10.1111/j.1469-0691.2004.00916.x
Few data regarding blood culture results in
Greece are available, and studies from other
countries have shown varying results [1–7].
Staphylococcus aureus is considered to be the
predominant pathogen [5,8,9], although coagu-
lase-negative staphylococci (CoNS) have become
more important in recent years [1,2,10–12]. In the
present study, all blood cultures performed in the
microbiology department of ‘Laikon’ General
Hospital from 1995 to 2002 were analysed retro-
spectively. ‘Laikon’ is a 500-bed tertiary care
hospital in Athens, affiliated with the Medical
School of Athens.
The automated BacT ⁄Alert system (Organon
Teknika, Durham, NC, USA) [13] was used for
blood culture monitoring. All positive bottles
were subcultured on to MacConkey and sheep
blood 5% v ⁄v agar plates, and preliminary
susceptibility testing was performed by the
Kirby–Bauer method directly from the bottle. If
the direct Gram’s stain and the subculture were
negative, the original automated result was con-
sidered to be a false-positive. Possible conta-
minants were considered as true causes of
bacteraemia only when the same strain was
isolated from two or more different blood cul-
tures, or from cultures of peripheral blood and
from an intravascular catheter tip after correlation
with clinical data. Isolates from positive blood
cultures were identified to the genus and species
levels by standard laboratory protocols, combined
with the PASCO semi-automated system (Becton
Dickinson, Cockeysville, MD, USA) and the API
(bioMe´rieux, Hazelwood, MO, USA) and BBL
Crystal (Becton Dickinson) biochemical reaction
panels, depending on the pathogen. Cultures
were considered to be negative after incubation
times of 5 days for common pathogens and
14 days for Brucella spp. The number of blood
cultures performed, the rates of true-positive,
false-positive and contamination, the number of
bacteraemias and organisms, and the mean time
to detection for each pathogen, were determined
for each year of the study. The number of
bloodstream infections (BSIs) ⁄ 1000 hospital
admissions (the attack rate), excluding short-term
stays, was calculated. Statistical analysis was
performed with the chi-square test.
As shown in Table 1, 57 815 blood cultures
were performed, of which 6108 (10.6%) were true-
positives. This figure corresponded to 3972 cases
of bacteraemia and an overall attack rate of 26.9.
The attack rate was analysed further with respect
to the four most common categories of microor-
ganisms (Fig. 1). Polymicrobial BSI accounted for
4.6% of the total (Table 1). The contamination rate
was 2.7%.
The most frequent microorganisms isolated
were: Escherichia coli, S. aureus, CoNS, enterococ-
ci, Klebsiella spp., Candida spp. and Pseudomonas
aeruginosa. E. coli and S. aureus were the most
common species for the entire period, except
during 2002, when CoNS ascended to first place
Table 1. Yearly results of blood cultures for the whole study period and grouped in two 4-year periods
1995 1996 1997 1998 1999 2000 2001 2002 Total p value 1995–1998 1999–2002 p value
Blood culture sets 4981 6280 6603 6543 7030 8242 9082 9054 57 815 24 407 33 408
True-positive 510 594 601 671 638 799 1130 1165 6108 2376 3732
n (%) (10.2) (9.5) (9.1) (10.3) (9.1) (9.7) (12.4) (12.9) (10.6) < 0.001 (9.7) (11.2) < 0.001
False-positive 165 247 161 84 46 19 61 61 844 657 187
n (%) (3.3) (3.9) (2.4) (1.3) (0.7) (0.2) (0.7) (0.7) (1.5) < 0.001 (2.7) (0.6) < 0.001
Cases of BSI 351 403 409 474 468 561 678 628 3972 1637 2335
Polymicrobial BSI 8 17 26 16 18 32 30 36 183 0.07 67 116 0.52
n (% of BSI) (2.3) (4.2) (6.4) (3.4) (3.8) (5.7) (4.4) (5.7) (4.6) (4.1) (5.0)
Admissions 15 910 16 503 17 834 18 598 18 005 20 135 20 290 20 468 147 743 68 845 78 898
Attack rate
Overall 22.1 24.4 22.9 25.5 26.0 27.9 33.4 30.7 26.9 < 0.001 23.8 29.6 < 0.001
Gram-negative 11.5 12.6 11.7 13.6 13.7 15.5 15.5 12.6 13.4 0.001 12.4 14.3 0.001
Gram-positive 8.5 10.8 10.7 11.4 11.3 12.6 17.3 17.7 12.8 < 0.001 10.4 14.8 < 0.001
Fungi 2.6 2.0 2.0 1.0 1.4 0.9 2.0 1.9 1.7 < 0.001 1.9 1.6 0.14
Anaerobes 0.1 0.1 0.1 0.4 0.7 0.5 0.3 0.4 0.3 0.007 0.2 0.5 0.005
BSI, bloodstream infections.
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(from fourth in 1995). In addition, enterococci,
which were isolated relatively infrequently be-
fore 1997, were included among the four
most common organisms thereafter. Candida
spp. re-emerged as the fifth most common
pathogen during 2001 and 2002. The mean times
to detection were 20.1 h for Gram-positive bac-
teria, 17.2 h for Gram-negative bacteria, 24.3 h
for fungi, 47.7 h for anaerobic bacteria, and
36.1 h for contaminants.
In the present study, there was a gradual
increase from 1995 to 2002 in the number of blood
cultures performed, the rate of positivity and the
attack rate, which is shown more clearly when the
results are expressed in two 4-year periods
(Table 1). These findings correlate with an increase
in hospital admissions, although this was not as
prominent. On the other hand, the BSI attack rate
was relatively high from 1995 onwards, and
increased to 30.7 in 2002. Most studies from Europe
[1–6] and the USA [7] report an attack rate of 2.7–
18.4. The higher rates reported in the present study
could be explained by the fact that a large propor-
tion of the patients admitted had a haematological
malignancy requiring immunosuppressive ther-
apy and use of central venous catheters, both of
which are significant risk factors for acquiring BSI
[14]. In addition, kidney transplant, HIV and
intensive care unit patients also represented a
significant proportion of admissions. An earlier
study in the same hospital [15] showed that most
positive blood cultures were from such patients.
A change in the relative frequencies of the
pathogens isolated was detected. Gram-negative
bacilli were more common originally, but Gram-
positive organisms outnumbered the Gram-neg-
ative organisms, accounting for 54.3% of BSIs in
2002, during the last 2 years of the study. This
change reflected the increase in CoNS and
enterococci bacteraemias (which doubled), while
S. aureus bacteraemias did not increase signifi-
cantly. This may also relate to the increased
hospitalisation of immunocompromised patients
and the emergence of vancomycin-resistant
enterococci and multiresistant CoNS. In contrast,
fungaemias have decreased, perhaps because of
antifungal prophylaxis given to patients with
febrile neutropenia. However, a study from Japan
[16] has suggested that antifungal chemoprophy-
laxis decreases the sensitivity of blood cultures,
and that antifungal agents should be inactivated
in culture bottles, a possibility that needs further
evaluation.
In the USA, Gram-positive cocci have been the
most common pathogens isolated since the late
1980s [17]. S. aureus was the predominant patho-
gen, followed by E. coli and CoNS [8,9,18,19], but
more recent studies have shown an increasing
trend of CoNS bacteraemias and, to a lesser
extent, Candida fungaemias [10], especially among
nosocomial BSIs [12]. In Europe, E. coli seems to
be the predominant pathogen [20], but CoNS are
the organisms isolated most commonly from
nosocomial BSIs [1,2]. It seems that Greece is
starting to experience the changes already noted
in other parts of the world.
In conclusion, the present study demonstrated
a gradual increase in the number of blood
cultures, rate of positivity and BSI attack rate,
reflecting the severity of the condition of hospi-
talised patients. During 2001 and 2002, as has
been noted earlier in other parts of the world,
Gram-positive bacteria were isolated more fre-
quently than Gram-negative bacteria because of
the continuously increasing frequency of isolation
of CoNS and enterococci.
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Fig. 1. Relative frequencies of main categories of blood
isolates evaluated as causes of true bloodstream infection
for the years 1995–2002.
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A B S T R A C T
Eighty-four children with mental retardation
(34 boys, 50 girls; age range 2–18 years, median
6 years) and 84 age- and gender-matched outpa-
tient controls were studied. All children were
living at home, had never stayed in an institution,
and came from the same urban area. Seropositiv-
ity for Helicobacter pylori was found in 42 (50%) of
84 mentally retarded children and 16 (19%) of
84 controls (p < 0.01). Socio-economic factors did
not differ between the two groups. The findings
indicated that a higher prevalence of H. pylori
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